AMDiGuard DNA Risk Test

About Visible Genomics

Visible Genomics is a commercial-stage diagnostics company specializing in genetic risk assessment for Age-Related Macular Degeneration (AMD). Its core offerings are the AMDiGuard Risk Test for general population screening and the AMDiGuard Progression Test for patients with early-stage disease, both delivered as physician-ordered DTC kits. The company targets the large and growing AMD patient population by empowering optometrists and ophthalmologists with tools for personalized, preventative eye care. Its business model is built on direct sales of test kits and establishing partnerships within eye care networks.

Therapeutic Areas